Skip to main content

Eli Lilly In 2017: Boom Or Bust?

On Thursday morning, pharmaceutical giant Eli Lilly ( LLY ) will unveil financial guidance for 2017. Some analysts think the forecasts could prove a bit disappointing, though not due to the setbacks with the company’s experimental Alzheimer’s drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.